Immuno-Biological Laboratories Co (TSE:4570) EV-to-EBIT : 30.12 (As of Apr. 26, 2025)

Immuno-Biological Laboratories Co EV-to-EBIT Chart

Immuno-Biological Laboratories Co Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-EBIT		Get a 7-Day Free Trial					-6.50	-14.93	-11.11	-12.20	35.28

Immuno-Biological Laboratories Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
EV-to-EBIT	Get a 7-Day Free Trial															-14.50	-41.31	-22.70	35.28	36.20

Competitive Comparison of Immuno-Biological Laboratories Co's EV-to-EBIT

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immuno-Biological Laboratories Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's EV-to-EBIT falls into.

Immuno-Biological Laboratories Co EV-to-EBIT Calculation

Immuno-Biological Laboratories Co's EV-to-EBIT for today is calculated as:

Immuno-Biological Laboratories Co's current Enterprise Value is 円3,787.7 Mil.
Immuno-Biological Laboratories Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円125.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuno-Biological Laboratories Co  (TSE:4570) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Immuno-Biological Laboratories Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Immuno-Biological Laboratories Co's Enterprise Value for the quarter that ended in Sep. 2024 was 円3,452.3 Mil.
Immuno-Biological Laboratories Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円125.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuno-Biological Laboratories Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuno-Biological Laboratories Co Business Description